Should I obtain a baseline plasma copeptin level together with a spot urine sodium in a patient being evaluated for diabetes insipidus with normal eGFR?

Should You Order Copeptin Baseline with Urine Sodium?

Yes, obtain baseline plasma copeptin together with spot urine sodium in patients being evaluated for diabetes insipidus with normal eGFR, as baseline copeptin >21.4 pmol/L is diagnostic for nephrogenic DI without requiring additional testing, while lower values guide the need for further stimulation tests.

Diagnostic Utility of Baseline Copeptin

The most recent international expert consensus (2025) provides clear guidance on copeptin's role in the diagnostic workup 1:

• Baseline copeptin levels above 21.4 pmol/L are diagnostic for nephrogenic diabetes insipidus (NDI) in adults without requiring additional testing, as these values are significantly higher than those seen in other polyuric disorders 1

• Baseline copeptin <21.4 pmol/L requires further testing with hypertonic saline or arginine stimulation to differentiate between central DI and primary polydipsia 1

• Copeptin is recommended as a suitable alternative to direct AVP measurement, which is unstable and cumbersome to measure 1

Why Order Both Tests Together

Ordering copeptin with urine sodium provides complementary diagnostic information:

• Urine sodium helps differentiate volume status and can be combined with copeptin in a ratio (copeptin:urine sodium) to distinguish volume-depleted from normovolemic disorders 2

• The copeptin to urinary sodium ratio accurately differentiates between volume-depleted and normovolemic disorders with 85% sensitivity and 87% specificity using a cutoff of 30 pmol/mmol 2

• In hyponatremia specifically, low copeptin levels with low urine osmolality identify primary polydipsia, while the copeptin:urinary sodium ratio distinguishes SIAD from other AVP-dependent forms 3, 2

Clinical Algorithm

For patients with polyuria-polydipsia syndrome:

1. Order baseline copeptin + spot urine sodium + serum osmolality + urine osmolality simultaneously 1

2. If baseline copeptin >21.4 pmol/L: Diagnose nephrogenic DI; no further dynamic testing needed 1

3. If baseline copeptin <21.4 pmol/L: Proceed to osmotic stimulation testing (hypertonic saline or arginine) to differentiate central DI from primary polydipsia 1

4. Use copeptin:urine sodium ratio to assess volume status if hyponatremia is present 2

Important Caveats

Genetic testing takes priority over copeptin in suspected congenital NDI:

• The 2025 consensus strongly recommends early genetic testing (AVPR2, AQP2, AVP genes) as the primary diagnostic approach 1

• Copeptin and other biochemical tests are recommended only when genetic testing is unavailable or inconclusive (5-10% of cases) 1

Pediatric considerations:

• Limited data exists on diagnostic copeptin values in pediatric polyuric disorders 1

• Recent pediatric data suggests arginine-stimulated copeptin with a cutoff of 3.8 pmol/L has 100% sensitivity and 86.5% specificity for CDI in children 4

Practical advantages of baseline measurement:

• Copeptin is stable in plasma and easily measured with sandwich immunoassay, unlike AVP 5, 3

• Baseline measurement (without prior fluid deprivation) can immediately identify NDI in most adult cases, avoiding the need for water deprivation testing 1, 5

• For indeterminate water deprivation test results, stimulated copeptin helps reclassify patients into final diagnostic groups 6